Cassava Sciences Inc.

News & Events

Press Releases

In The Media

1. Cassava Reports Q1 2025 Financials Results, Provides Business Update

   GlobeNewswire MAY 8, 2025 8:00 AM EDT
   License agreement and recent leadership appointments position Cassava to advance development of s...
   READ ARTICLE

2. Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

   GlobeNewswire MAY 1, 2025 7:30 AM EDT
   As SVP, Neuroscience, Dr. Bordey will lead Cassava’s ongoing research and development effo...
   READ ARTICLE

3. Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

   GlobeNewswire APR 21, 2025 4:30 PM EDT
   AUSTIN, Texas, April 21, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “C...
   READ ARTICLE

4. Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

   GlobeNewswire MAR 25, 2025 8:05 AM EDT
   Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional...
   READ ARTICLE

5. Cassava Sciences Reports 2024 Financial Results and Provides Business Update

   GlobeNewswire MAR 3, 2025 7:30 AM EST
   Top-line data for REFOCUS-ALZ, the second Phase 3 study of simufilam in Alzheimer’s diseas...
   READ ARTICLE

6. Cassava Sciences Licenses Simufilam Method of Treatment Patent

   GlobeNewswire FEB 27, 2025 7:00 AM EST
   Cassava enters into a license agreement with Yale University granting intellectual property right...
   READ ARTICLE

7. FINAL REMINDER SAVA DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Cassava Sciences, Inc. Investors to Participate in the Class Action Lawsuit

   Newsfile FEB 10, 2025 4:00 PM EST
   New York, New York--(Newsfile Corp. - February 10, 2025) - Bronstein, Gewirtz & Grossman, LLC...
   READ ARTICLE

8. SAVA Deadline Today: SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit

   PR Newswire FEB 10, 2025 3:59 PM EST
   SAVA Deadline Today: SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fr...
   READ ARTICLE

9. Cassava Sciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SAVA

   GlobeNewswire FEB 10, 2025 1:28 PM EST
   NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cas...
   READ ARTICLE

10. SAVA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - SAVA

    Newsfile FEB 10, 2025 12:25 PM EST
    New York, New York--(Newsfile Corp. - February 10, 2025) - WHY:  Rosen Law Firm, a global i...
    READ ARTICLE